The tariff classification of Paclitaxel (CAS-33069-62-4), in bulk form, from India; Cisapride (CAS-81098-60-4), in bulk form, from India; and Naproxen Sodium (CAS-26159-34-2), in bulk form, from England
Reasoning
The tariff classification of Paclitaxel (CAS-33069-62-4), in bulk form, from India; Cisapride (CAS-81098-60-4), in bulk form, from India; and Naproxen Sodium (CAS-26159-34-2), in bulk form, from England
Cite this ruling
CBP Ruling A89994 (2932996000): The tariff classification of Paclitaxel (CAS-33069-62-4), in bulk form, from India; Cisapride (CAS-81098-60-4), in bulk form, from India; and Naproxen Sodium (CAS-26159-34-2), in bulk form, from England
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 293299
Protest 1001-99-105522; Quercetin
The tariff classification of Glycerol Formal (CAS 86687-05-5) from Belgium.
The tariff classification of Estra-5(10), 9(11)-Diene-17-One-3-Ethylene Glycol Ketal (CAS 5571-36-8) from China.
The tariff classification of D-Glucuronic Acid (CAS 6556-12-3) from Switzerland.
The tariff classification of Cromafiban from France.